Cikloserin (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cikloserin" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

4^th place

8^th place

2^nd place

5^th place

low place

34^th place

399^th place

169^th place

838^th place

139^th place

195^th place

64^th place

6^th place

9^th place

archive.org

Nitsche, Michael; Jaussi, W.; Liebetanz, D.; Lang, N.; Tergau, F.; Paulus, W. (2004). »Consolidation of human motor cortical neuroplasticity by D-cycloserine«. Neuropsychopharmacology. 29 (8): 1573–1578. doi:10.1038/sj.npp.1300517. PMID 15199378.
Ori, R; Amos, T; Bergman, H; Soares-Weiser, K; Ipser, JC; Stein, DJ (10. maj 2015). »Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders«. The Cochrane database of systematic reviews. 5: CD007803. doi:10.1002/14651858.CD007803.pub2. PMID 25957940.
Schade, S; Paulus, W (12. september 2015). »D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review«. The International Journal of Neuropsychopharmacology. 19: pyv102. doi:10.1093/ijnp/pyv102. PMC 4851259. PMID 26364274.
Myers, KM; Carlezon WA, Jr (1. junij 2012). »D-cycloserine effects on extinction of conditioned responses to drug-related cues«. Biological Psychiatry. 71 (11): 947–55. doi:10.1016/j.biopsych.2012.02.030. PMC 4001849. PMID 22579305.
Prosser, Gareth; de Carvalho, Luiz Pedro S. (Februar 2013). »Kinetic mechanism and inhibition of Mycobacterium tuberculosis d-alanine: D-alanine ligase by the antibiotic d-cycloserine«. FEBS Journal. 280 (4): 1150–1166. doi:10.1111/febs.12108. PMID 23286234.

»Cycloserine«. The American Society of Health-System Pharmacists. Pridobljeno 8. decembra 2016.

Gottlieb, David; Shaw, Paul D. (2012). Mechanism of Action (v angleščini). Springer Science & Business Media. str. 41. ISBN 9783642460517.

Nitsche, Michael; Jaussi, W.; Liebetanz, D.; Lang, N.; Tergau, F.; Paulus, W. (2004). »Consolidation of human motor cortical neuroplasticity by D-cycloserine«. Neuropsychopharmacology. 29 (8): 1573–1578. doi:10.1038/sj.npp.1300517. PMID 15199378.
Ori, R; Amos, T; Bergman, H; Soares-Weiser, K; Ipser, JC; Stein, DJ (10. maj 2015). »Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders«. The Cochrane database of systematic reviews. 5: CD007803. doi:10.1002/14651858.CD007803.pub2. PMID 25957940.
Schade, S; Paulus, W (12. september 2015). »D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review«. The International Journal of Neuropsychopharmacology. 19: pyv102. doi:10.1093/ijnp/pyv102. PMC 4851259. PMID 26364274.
Myers, KM; Carlezon WA, Jr (1. junij 2012). »D-cycloserine effects on extinction of conditioned responses to drug-related cues«. Biological Psychiatry. 71 (11): 947–55. doi:10.1016/j.biopsych.2012.02.030. PMC 4001849. PMID 22579305.
Lambert, M. P. (1972). »Mechanism of D-cycloserine action: Alanine racemase from Escherichia coli W«. Journal of Bacteriology. 110 (3): 978–987. PMC 247518. PMID 4555420.
Prosser, Gareth; de Carvalho, Luiz Pedro S. (Februar 2013). »Kinetic mechanism and inhibition of Mycobacterium tuberculosis d-alanine: D-alanine ligase by the antibiotic d-cycloserine«. FEBS Journal. 280 (4): 1150–1166. doi:10.1111/febs.12108. PMID 23286234.

»WHO Model List of Essential Medicines (19th List)« (PDF). World Health Organization. april 2015. Pridobljeno 8. decembra 2016.{{navedi splet}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)